Bruker Corporation (BRKR)

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
United States Revenue	891.30M	938.50M
United States Revenue Growth	-5.03%	20.68%
Germany Revenue	-	310.70M
Germany Revenue Growth	-	10.37%
Rest of Europe Revenue	-	873.00M
Rest of Europe Revenue Growth	-	24.77%
China Revenue	-	471.20M
China Revenue Growth	-	-10.77%
Rest of Asia Pacific Revenue	-	518.50M
Rest of Asia Pacific Revenue Growth	-	12.50%
Total Asia Pacific Revenue	1.03B	989.70M
Total Asia Pacific Revenue Growth	3.91%	0.07%
Other Countries Revenue	269.60M	254.50M
Other Countries Revenue Growth	5.93%	17.50%
Revenue (Other)	1.25B	-
Revenue (Total)	3.44B	3.37B
Revenue (Total) Growth	2.08%	13.56%

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BSI BioSpin Revenue	878.80M	905.70M
BSI BioSpin Revenue Growth	-2.97%	13.43%
BSI CALID Revenue	1.21B	1.09B
BSI CALID Revenue Growth	10.67%	13.86%
BSI Life Science Revenue	2.09B	2.00B
BSI Life Science Revenue Growth	4.49%	13.66%
BSI Nano Revenue	1.08B	1.10B
BSI Nano Revenue Growth	-1.27%	16.61%
Total BSI Revenue	3.17B	3.10B
Total BSI Revenue Growth	2.45%	14.69%
BEST Revenue	270.90M	283.00M
BEST Revenue Growth	-4.28%	0.82%
Eliminations from Revenue	-7.70M	-14.10M
Revenue (Total)	3.44B	3.37B
Revenue (Total) Growth	2.08%	13.56%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BSI BioSpin Operating Income	-	157.80M
BSI BioSpin Operating Income Growth	-	-19.45%
BSI CALID Operating Income	-	180.00M
BSI CALID Operating Income Growth	-	-14.00%
BSI Life Science Operating Income	-	337.80M
BSI Life Science Operating Income Growth	-	-16.63%
BSI Nano Operating Income	-	2.30M
BSI Nano Operating Income Growth	-	-97.89%
Corporate, Eliminations and Other Operating Income	-	-121.90M
Total BSI Operating Income	-	218.20M
Total BSI Operating Income Growth	-	-46.07%
BEST Operating Income	-	34.90M
BEST Operating Income Growth	-	8.05%
Operating Income (Total)	68.20M	253.10M
Operating Income (Total) Growth	-73.05%	-42.07%

Capital Expenditures

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BSI BioSpin Capital Expenditures	22.80M
BSI BioSpin Capital Expenditures Growth	-4.60%
BSI CALID Capital Expenditures	34.10M
BSI CALID Capital Expenditures Growth	8.60%
BSI Life Science Capital Expenditures	56.90M
BSI Life Science Capital Expenditures Growth	2.89%
BSI Nano Capital Expenditures	19.30M
BSI Nano Capital Expenditures Growth	38.85%
Corporate Capital Expenditures	14.80M
Corporate Capital Expenditures Growth	45.10%
Total BSI Capital Expenditures	91.00M
Total BSI Capital Expenditures Growth	14.61%
BEST Capital Expenditures	24.30M
BEST Capital Expenditures Growth	-11.64%

Updated Feb 12, 2026. Data Source: Fiscal.ai.